Zhang S H, Liu M, Asplund K, Li L
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003317. doi: 10.1002/14651858.CD003317.pub2.
Acupuncture-like sensory stimulation activates multiple efferent (nerve) pathways leading to altered activity in numerous neural systems. Acupuncture is widely accepted by Chinese people and it is increasingly requested by patients and their relatives in Western countries.
To assess the effectiveness and safety of acupuncture in patients with acute stroke.
We searched the Cochrane Stroke Group trials register (last searched August 2003), the Chinese Stroke Trials Register (August 2003) and the Chinese Acupuncture Trials Register (August 2003). Electronic searches were performed in the Cochrane Controlled Trials Register (The Cochrane Library, Issue 3, 2003), MEDLINE (1966 to 2003), EMBASE (1980 to 2003), Alternative Medicine Database (1985 to 2003), CINAHL (1982 to 2003) and the Chinese Biological Medicine Database (1981 to 2003). Reference lists of systematic reviews and identified trials were handsearched.
Randomised and quasi-randomised trials of acupuncture started within 30 days of stroke onset, compared with placebo/sham acupuncture or open control in patients with acute ischaemic and/or haemorrhagic stroke. Needling into skin was required for acupuncture.
Two reviewers selected trials for inclusion, assessed trial quality, and extracted the data independently. Authors of trials were contacted for missing data.
Fourteen trials involving 1208 patients were included. Ten trials included patients with only ischaemic stroke. When acupuncture was compared with sham acupuncture or open control, there was a borderline significant trend towards fewer patients being dead or dependent (Odds ratio (OR) 0.66, 95% confidence interval (CI) 0.43 to 0.99), and significantly fewer being dead or needing institutional care (OR 0.58, 95% CI 0.35 to 0.96) in the acupuncture group after three months or more. There was also a significant difference favouring acupuncture in the mean change of global neurological deficit score during the treatment period (standardized mean difference (SMD) 1.17, 95% CI 0.30 to 2.04). Comparison of acupuncture with sham acupuncture only showed a statistically significant difference on death or requiring institutional care (OR 0.49, 95% CI 0.25 to 0.96), but not on death or dependency (OR 0.67, 95% CI 0.40 to 1.12), or change of global neurological deficit score (SMD 0.01, 95% CI -0.55 to 0.57). Severe adverse events with acupuncture (dizziness, intolerable pain and infection of acupoints) were rare (6/386, 1.55%).
AUTHORS' CONCLUSIONS: Acupuncture appeared to be safe but without clear evidence of benefit. The number of patients is too small to be certain whether acupuncture is effective for treatment of acute ischaemic or haemorrhagic stroke. Larger, methodologically-sound trials are required.
针刺样感觉刺激可激活多条传出(神经)通路,导致众多神经系统的活动发生改变。针灸在中国被广泛接受,在西方国家,患者及其亲属对其需求也日益增加。
评估针灸治疗急性脑卒中患者的有效性和安全性。
我们检索了Cochrane卒中组试验注册库(最后检索时间为2003年8月)、中国卒中试验注册库(2003年8月)和中国针灸试验注册库(2003年8月)。还在Cochrane对照试验注册库(《Cochrane图书馆》,2003年第3期)、MEDLINE(1966年至2003年)、EMBASE(1980年至2003年)、替代医学数据库(1985年至2003年)、CINAHL(1982年至2003年)和中国生物医学数据库(1981年至2003年)中进行了电子检索。对系统评价和已识别试验的参考文献列表进行了手工检索。
卒中发作30天内开始的针灸随机和半随机试验,与急性缺血性和/或出血性卒中患者的安慰剂/假针灸或开放对照进行比较。针灸需针刺入皮肤。
两名评价者选择纳入试验,评估试验质量,并独立提取数据。与试验作者联系获取缺失数据。
纳入了14项试验,涉及1208例患者。10项试验仅纳入了缺血性卒中患者。当将针灸与假针灸或开放对照进行比较时,在三个月或更长时间后,针灸组中死亡或依赖的患者人数有边缘显著减少的趋势(优势比(OR)0.66,95%置信区间(CI)0.43至0.99),死亡或需要机构护理的患者人数显著减少(OR 0.58,95%CI 0.35至0.96)。在治疗期间,针灸组在总体神经功能缺损评分的平均变化方面也有显著差异(标准化均数差(SMD)1.17,95%CI 0.30至2.04)。仅将针灸与假针灸进行比较时,在死亡或需要机构护理方面显示出统计学显著差异(OR 0.49,95%CI 0.25至0.96),但在死亡或依赖方面无差异(OR 0.67,95%CI 0.40至1.12),在总体神经功能缺损评分变化方面也无差异(SMD 0.01,95%CI -0.55至0.57)。针灸的严重不良事件(头晕、难以忍受的疼痛和穴位感染)很少见(6/386,1.55%)。
针灸似乎是安全的,但没有明确的获益证据。患者数量太少,无法确定针灸对急性缺血性或出血性卒中的治疗是否有效。需要进行更大规模、方法学合理的试验。